These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 20370791)

  • 1. Natural antioxidants and hypertension: promise and challenges.
    Kizhakekuttu TJ; Widlansky ME
    Cardiovasc Ther; 2010 Aug; 28(4):e20-32. PubMed ID: 20370791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting reactive oxygen species in hypertension.
    Delles C; Miller WH; Dominiczak AF
    Antioxid Redox Signal; 2008 Jun; 10(6):1061-77. PubMed ID: 18321202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
    Touyz RM
    Hypertension; 2004 Sep; 44(3):248-52. PubMed ID: 15262903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies.
    Montezano AC; Dulak-Lis M; Tsiropoulou S; Harvey A; Briones AM; Touyz RM
    Can J Cardiol; 2015 May; 31(5):631-41. PubMed ID: 25936489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitochondrial oxidative stress in hypertension.
    Dikalov SI; Ungvari Z
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(10):H1417-27. PubMed ID: 24043248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
    Siti HN; Kamisah Y; Kamsiah J
    Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is oxidative stress a therapeutic target in cardiovascular disease?
    Münzel T; Gori T; Bruno RM; Taddei S
    Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis.
    Violi F; Pastori D; Pignatelli P; Loffredo L
    Europace; 2014 Aug; 16(8):1107-16. PubMed ID: 24706090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of reactive oxygen species in systemic and pulmonary hypertension.
    Zuo L; Rose BA; Roberts WJ; He F; Banes-Berceli AK
    Am J Hypertens; 2014 May; 27(5):643-50. PubMed ID: 24552887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant therapy for management of oxidative stress induced hypertension.
    Ahmad KA; Yuan Yuan D; Nawaz W; Ze H; Zhuo CX; Talal B; Taleb A; Mais E; Qilong D
    Free Radic Res; 2017 Apr; 51(4):428-438. PubMed ID: 28427291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.
    Victor VM; Apostolova N; Herance R; Hernandez-Mijares A; Rocha M
    Curr Med Chem; 2009; 16(35):4654-67. PubMed ID: 19903143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and endothelial function: therapeutic interventions.
    Tousoulis D; Briasoulis A; Papageorgiou N; Tsioufis C; Tsiamis E; Toutouzas K; Stefanadis C
    Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):103-14. PubMed ID: 21513492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and vascular stiffness in hypertension: A renewed interest for antioxidant therapies?
    Massaro M; Scoditti E; Carluccio MA; De Caterina R
    Vascul Pharmacol; 2019 May; 116():45-50. PubMed ID: 30946986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension.
    Amaral JH; Ferreira GC; Pinheiro LC; Montenegro MF; Tanus-Santos JE
    Redox Biol; 2015 Aug; 5():340-346. PubMed ID: 26119848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular sources of reactive oxygen species in hypertension.
    Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
    Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.
    Coats A; Jain S
    J Hum Hypertens; 2017 Jun; 31(6):376-381. PubMed ID: 28252041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive role of polyphenols.
    Rodrigo R; Gil D; Miranda-Merchak A; Kalantzidis G
    Adv Clin Chem; 2012; 58():225-54. PubMed ID: 22950347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects and mechanisms of chlorogenic acids.
    Zhao Y; Wang J; Ballevre O; Luo H; Zhang W
    Hypertens Res; 2012 Apr; 35(4):370-4. PubMed ID: 22072103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.
    Houston MC
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.